Ocugen Inc (OCGN)
1.735
+0.02
(+1.46%)
USD |
NASDAQ |
Jul 08, 16:00
1.73
0.00 (0.00%)
After-Hours: 20:00
Ocugen SG&A Expense (Annual): 31.99M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 31.99M |
| December 31, 2022 | 35.40M |
| December 31, 2021 | 22.92M |
| December 31, 2020 | 7.974M |
| December 31, 2019 | 6.077M |
| December 31, 2018 | 10.20M |
| Date | Value |
|---|---|
| December 31, 2017 | 9.384M |
| December 31, 2016 | 8.53M |
| December 31, 2015 | 8.266M |
| December 31, 2014 | 6.565M |
| December 31, 2013 | 4.847M |
| December 31, 2012 | 3.053M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
6.077M
Minimum
2019
35.40M
Maximum
2022
20.87M
Average
22.92M
Median
2021
SG&A Expense (Annual) Benchmarks
| QuidelOrtho Corp | 763.20M |
| Checkpoint Therapeutics Inc | 8.685M |
| Johnson & Johnson | 20.11B |
| Imunon Inc | 9.743M |
| iBio Inc | 19.02M |